-
1
-
-
0037586420
-
Gastric cancer: epidemiology, pathology and treatment
-
Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003; 14(Suppl 2):ii31-36.
-
(2003)
Ann Oncol.
, vol.14
, pp. ii31-ii36
-
-
Alberts, S.R.1
Cervantes, A.2
van de Velde, C.J.3
-
2
-
-
33646568784
-
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world
-
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24:2137-2150.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2137-2150
-
-
Kamangar, F.1
Dores, G.M.2
Anderson, W.F.3
-
4
-
-
34648820472
-
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute
-
Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann Surg Oncol. 2007; 14:2730-2737.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 2730-2737
-
-
Moon, Y.W.1
Jeung, H.C.2
Rha, S.Y.3
Yoo, N.C.4
Roh, J.K.5
Noh, S.H.6
Kim, B.S.7
Chung, H.C.8
-
5
-
-
0037967272
-
Tumorigenesis and the angiogenic switch
-
Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003; 3:401-410.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 401-410
-
-
Bergers, G.1
Benjamin, L.E.2
-
6
-
-
84905858700
-
Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment
-
Barzi A, Thara E. Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment. Expert Opin Biol Ther. 2014; 14:1319-1332.
-
(2014)
Expert Opin Biol Ther
, vol.14
, pp. 1319-1332
-
-
Barzi, A.1
Thara, E.2
-
7
-
-
0027751663
-
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
-
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75:843-854.
-
(1993)
Cell
, vol.75
, pp. 843-854
-
-
Lee, R.C.1
Feinbaum, R.L.2
Ambros, V.3
-
10
-
-
70349976210
-
MicroRNAs: novel regulators in the hallmarks of human cancer
-
Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett. 2009; 285:116-126.
-
(2009)
Cancer Lett
, vol.285
, pp. 116-126
-
-
Ruan, K.1
Fang, X.2
Ouyang, G.3
-
11
-
-
60149084560
-
MicroRNAs and cancer: short RNAs go a long way
-
Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell. 2009; 136:586-591.
-
(2009)
Cell
, vol.136
, pp. 586-591
-
-
Ventura, A.1
Jacks, T.2
-
12
-
-
77649275464
-
miR-9, a MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis
-
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, et al. miR-9, a MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol. 2010; 12:247-256.
-
(2010)
Nat Cell Biol
, vol.12
, pp. 247-256
-
-
Ma, L.1
Young, J.2
Prabhala, H.3
Pan, E.4
Mestdagh, P.5
Muth, D.6
Teruya-Feldstein, J.7
Reinhardt, F.8
Onder, T.T.9
Valastyan, S.10
Westermann, F.11
Speleman, F.12
-
13
-
-
79251585937
-
The prognostic and functional role of microRNAs in acute myeloid leukemia
-
Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood. 2011; 117:1121-1129.
-
(2011)
Blood
, vol.117
, pp. 1121-1129
-
-
Marcucci, G.1
Mrozek, K.2
Radmacher, M.D.3
Garzon, R.4
Bloomfield, C.D.5
-
14
-
-
77956915352
-
miR-126 functions as a tumour suppressor in human gastric cancer
-
Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010; 298:50-63.
-
(2010)
Cancer Lett
, vol.298
, pp. 50-63
-
-
Feng, R.1
Chen, X.2
Yu, Y.3
Su, L.4
Yu, B.5
Li, J.6
Cai, Q.7
Yan, M.8
Liu, B.9
Zhu, Z.10
-
15
-
-
35148886434
-
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
-
Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449:682-688.
-
(2007)
Nature
, vol.449
, pp. 682-688
-
-
Ma, L.1
Teruya-Feldstein, J.2
Weinberg, R.A.3
-
16
-
-
55549114664
-
The miR-15amiR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
-
Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, et al. The miR-15amiR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med. 2008; 14:1271-1277.
-
(2008)
Nat Med
, vol.14
, pp. 1271-1277
-
-
Bonci, D.1
Coppola, V.2
Musumeci, M.3
Addario, A.4
Giuffrida, R.5
Memeo, L.6
D'Urso, L.7
Pagliuca, A.8
Biffoni, M.9
Labbaye, C.10
Bartucci, M.11
Muto, G.12
Peschle, C.13
-
17
-
-
77950622025
-
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma
-
Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, Yan M, Ge C, Zhang Z, Chen T, Wan D, Yao M, Li J, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010; 51:846-856.
-
(2010)
Hepatology
, vol.51
, pp. 846-856
-
-
Yao, J.1
Liang, L.2
Huang, S.3
Ding, J.4
Tan, N.5
Zhao, Y.6
Yan, M.7
Ge, C.8
Zhang, Z.9
Chen, T.10
Wan, D.11
Yao, M.12
Li, J.13
-
18
-
-
39049086391
-
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
-
Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 2008; 68:425-433.
-
(2008)
Cancer Res
, vol.68
, pp. 425-433
-
-
Yang, H.1
Kong, W.2
He, L.3
Zhao, J.J.4
O'Donnell, J.D.5
Wang, J.6
Wenham, R.M.7
Coppola, D.8
Kruk, P.A.9
Nicosia, S.V.10
Cheng, J.Q.11
-
19
-
-
52949090784
-
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis
-
Suarez Y, Fernandez-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A. 2008; 105:14082-14087.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 14082-14087
-
-
Suarez, Y.1
Fernandez-Hernando, C.2
Yu, J.3
Gerber, S.A.4
Harrison, K.D.5
Pober, J.S.6
Iruela-Arispe, M.L.7
Merkenschlager, M.8
Sessa, W.C.9
-
20
-
-
15744391012
-
Dicer is required for embryonic angiogenesis during mouse development
-
Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J Biol Chem. 2005; 280:9330-9335.
-
(2005)
J Biol Chem
, vol.280
, pp. 9330-9335
-
-
Yang, W.J.1
Yang, D.D.2
Na, S.3
Sandusky, G.E.4
Zhang, Q.5
Zhao, G.6
-
21
-
-
48749130187
-
miR-126 regulates angiogenic signaling and vascular integrity
-
Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15:272-284.
-
(2008)
Dev Cell
, vol.15
, pp. 272-284
-
-
Fish, J.E.1
Santoro, M.M.2
Morton, S.U.3
Yu, S.4
Yeh, R.F.5
Wythe, J.D.6
Ivey, K.N.7
Bruneau, B.G.8
Stainier, D.Y.9
Srivastava, D.10
-
22
-
-
48549106378
-
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
-
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008; 15:261-271.
-
(2008)
Dev Cell
, vol.15
, pp. 261-271
-
-
Wang, S.1
Aurora, A.B.2
Johnson, B.A.3
Qi, X.4
McAnally, J.5
Hill, J.A.6
Richardson, J.A.7
Bassel-Duby, R.8
Olson, E.N.9
-
23
-
-
60849106298
-
Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126
-
Kuhnert F, Mancuso MR, Hampton J, Stankunas K, Asano T, Chen CZ, Kuo CJ. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008; 135:3989-3993.
-
(2008)
Development
, vol.135
, pp. 3989-3993
-
-
Kuhnert, F.1
Mancuso, M.R.2
Hampton, J.3
Stankunas, K.4
Asano, T.5
Chen, C.Z.6
Kuo, C.J.7
-
24
-
-
79952198215
-
In vitro functional study of miR-126 in leukemia
-
Li Z, Chen J. In vitro functional study of miR-126 in leukemia. Methods Mol Biol. 2011; 676:185-195.
-
(2011)
Methods Mol Biol
, vol.676
, pp. 185-195
-
-
Li, Z.1
Chen, J.2
-
25
-
-
84655175072
-
down-regulation of miR-126 expression in colorectal cancer and its clinical significance
-
Li XM, Wang AM, Zhang J, Yi H. down-regulation of miR-126 expression in colorectal cancer and its clinical significance. Med Oncol. 2011; 28:1054-1057.
-
(2011)
Med Oncol
, vol.28
, pp. 1054-1057
-
-
Li, X.M.1
Wang, A.M.2
Zhang, J.3
Yi, H.4
-
26
-
-
84891905863
-
MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways
-
Liu Y, Zhou Y, Feng X, An P, Quan X, Wang H, Ye S, Yu C, He Y, Luo H. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways. Int J Oncol. 2014; 44:203-210.
-
(2014)
Int J Oncol
, vol.44
, pp. 203-210
-
-
Liu, Y.1
Zhou, Y.2
Feng, X.3
An, P.4
Quan, X.5
Wang, H.6
Ye, S.7
Yu, C.8
He, Y.9
Luo, H.10
-
27
-
-
58549108465
-
Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells
-
Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun. 2009; 379:726-731.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 726-731
-
-
Saito, Y.1
Friedman, J.M.2
Chihara, Y.3
Egger, G.4
Chuang, J.C.5
Liang, G.6
-
28
-
-
54449099588
-
The cell growth suppressor, mir-126, targets IRS-1
-
Zhang J, Du YY, Lin YF, Chen YT, Yang L, Wang HJ, Ma D. The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun. 2008; 377:136-140.
-
(2008)
Biochem Biophys Res Commun
, vol.377
, pp. 136-140
-
-
Zhang, J.1
Du, Y.Y.2
Lin, Y.F.3
Chen, Y.T.4
Yang, L.5
Wang, H.J.6
Ma, D.7
-
29
-
-
84901440651
-
Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro
-
Yang X, Wu H, Ling T. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro. Mol Med Rep. 2014; 10:125-130.
-
(2014)
Mol Med Rep
, vol.10
, pp. 125-130
-
-
Yang, X.1
Wu, H.2
Ling, T.3
-
30
-
-
66049084202
-
MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo
-
Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009; 66:169-175.
-
(2009)
Lung Cancer
, vol.66
, pp. 169-175
-
-
Liu, B.1
Peng, X.C.2
Zheng, X.L.3
Wang, J.4
Qin, Y.W.5
-
31
-
-
84866653610
-
let-b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-smallcell lung cancer
-
Jusufovic E, Rijavec M, Keser D, Korosec P, Sodja E, Iljazovic E, Radojevic Z, Kosnik M. let-b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non-smallcell lung cancer. PLoS One. 2012; 7:e45577.
-
(2012)
PLoS One
, vol.7
-
-
Jusufovic, E.1
Rijavec, M.2
Keser, D.3
Korosec, P.4
Sodja, E.5
Iljazovic, E.6
Radojevic, Z.7
Kosnik, M.8
-
32
-
-
40949091473
-
The role of Egfl7 in vascular morphogenesis
-
discussion 28-36, 238-241
-
Schmidt M, De Maziere A, Smyczek T, Gray A, Parker L, Filvaroff E, French D, van Dijk S, Klumperman J, Ye W. The role of Egfl7 in vascular morphogenesis. Novartis Found Symp. 2007; 283:18-28; discussion 28-36, 238-241.
-
(2007)
Novartis Found Symp
, vol.283
, pp. 18-28
-
-
Schmidt, M.1
De Maziere, A.2
Smyczek, T.3
Gray, A.4
Parker, L.5
Filvaroff, E.6
French, D.7
van Dijk, S.8
Klumperman, J.9
Ye, W.10
-
33
-
-
48949115082
-
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines
-
Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, Nuovo G, Marsh CB, Nana-Sinkam SP. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 2008; 373:607-612.
-
(2008)
Biochem Biophys Res Commun
, vol.373
, pp. 607-612
-
-
Crawford, M.1
Brawner, E.2
Batte, K.3
Yu, L.4
Hunter, M.G.5
Otterson, G.A.6
Nuovo, G.7
Marsh, C.B.8
Nana-Sinkam, S.P.9
-
34
-
-
40349103409
-
MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1
-
Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A. 2008; 105:1516-1521.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 1516-1521
-
-
Harris, T.A.1
Yamakuchi, M.2
Ferlito, M.3
Mendell, J.T.4
Lowenstein, C.J.5
-
35
-
-
84861878901
-
miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
-
Zhu X, Li H, Long L, Hui L, Chen H, Wang X, Shen H, Xu W. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim Biophys Sin (Shanghai). 2012; 44:519-526.
-
(2012)
Acta Biochim Biophys Sin (Shanghai)
, vol.44
, pp. 519-526
-
-
Zhu, X.1
Li, H.2
Long, L.3
Hui, L.4
Chen, H.5
Wang, X.6
Shen, H.7
Xu, W.8
-
36
-
-
79953702227
-
Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
-
Zhu N, Zhang D, Xie H, Zhou Z, Chen H, Hu T, Bai Y, Shen Y, Yuan W, Jing Q, Qin Y. Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2. Mol Cell Biochem. 2011; 351:157-164.
-
(2011)
Mol Cell Biochem
, vol.351
, pp. 157-164
-
-
Zhu, N.1
Zhang, D.2
Xie, H.3
Zhou, Z.4
Chen, H.5
Hu, T.6
Bai, Y.7
Shen, Y.8
Yuan, W.9
Jing, Q.10
Qin, Y.11
-
37
-
-
84864881089
-
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
-
Sasahira T, Kurihara M, Bhawal UK, Ueda N, Shimomoto T, Yamamoto K, Kirita T, Kuniyasu H. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer. 2012; 107:700-706.
-
(2012)
Br J Cancer
, vol.107
, pp. 700-706
-
-
Sasahira, T.1
Kurihara, M.2
Bhawal, U.K.3
Ueda, N.4
Shimomoto, T.5
Yamamoto, K.6
Kirita, T.7
Kuniyasu, H.8
-
38
-
-
79551511687
-
MicroRNA-12 inhibits SOX2 expression and contributes to gastric carcinogenesis
-
Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K, Yuasa Y. MicroRNA-12 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One. 2011; 6:e16617.
-
(2011)
PLoS One
, vol.6
-
-
Otsubo, T.1
Akiyama, Y.2
Hashimoto, Y.3
Shimada, S.4
Goto, K.5
Yuasa, Y.6
-
39
-
-
84970070220
-
Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
-
Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995; 55:3964-3968.
-
(1995)
Cancer Res
, vol.55
, pp. 3964-3968
-
-
Takahashi, Y.1
Kitadai, Y.2
Bucana, C.D.3
Cleary, K.R.4
Ellis, L.M.5
-
40
-
-
0030066037
-
Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
-
Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996; 77:858-863.
-
(1996)
Cancer
, vol.77
, pp. 858-863
-
-
Maeda, K.1
Chung, Y.S.2
Ogawa, Y.3
Takatsuka, S.4
Kang, S.M.5
Ogawa, M.6
Sawada, T.7
Sowa, M.8
-
41
-
-
0038792746
-
Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction
-
Partin JV, Anglin IE, Kyprianou N. Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction. Br J Cancer. 2003; 88:1615-1621.
-
(2003)
Br J Cancer
, vol.88
, pp. 1615-1621
-
-
Partin, J.V.1
Anglin, I.E.2
Kyprianou, N.3
-
42
-
-
84878477682
-
Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth
-
Wang X, Chen X, Fang J, Yang C. Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth. Int J Clin Exp Pathol. 2013; 6:586-597.
-
(2013)
Int J Clin Exp Pathol
, vol.6
, pp. 586-597
-
-
Wang, X.1
Chen, X.2
Fang, J.3
Yang, C.4
-
43
-
-
33750318273
-
A guide through present computational approaches for the identification of mammalian microRNA targets
-
Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods. 2006; 3:881-886.
-
(2006)
Nat Methods
, vol.3
, pp. 881-886
-
-
Sethupathy, P.1
Megraw, M.2
Hatzigeorgiou, A.G.3
-
44
-
-
84904389111
-
Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2
-
Liu LY, Wang W, Zhao LY, Guo B, Yang J, Zhao XG, Hou N, Ni L, Wang AY, Song TS, Huang C, Xu JR. Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2. Int J Oncol. 2014; 45:1257-1265.
-
(2014)
Int J Oncol
, vol.45
, pp. 1257-1265
-
-
Liu, L.Y.1
Wang, W.2
Zhao, L.Y.3
Guo, B.4
Yang, J.5
Zhao, X.G.6
Hou, N.7
Ni, L.8
Wang, A.Y.9
Song, T.S.10
Huang, C.11
Xu, J.R.12
-
45
-
-
84871695308
-
Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα
-
Feng X, Wang H, Ye S, Guan J, Tan W, Cheng S, Wei G, Wu W, Wu F, Zhou Y. Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα. PLoS One. 2012; 7:e52782.
-
(2012)
PLoS One
, vol.7
-
-
Feng, X.1
Wang, H.2
Ye, S.3
Guan, J.4
Tan, W.5
Cheng, S.6
Wei, G.7
Wu, W.8
Wu, F.9
Zhou, Y.10
-
46
-
-
84919964878
-
Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR-126 in esophageal squamous cell carcinoma
-
Li H, Meng F, Ma J, Yu Y, Hua X, Qin J, Li Y. Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR-126 in esophageal squamous cell carcinoma. Oncol Rep. 2014; 32:1225-1233.
-
(2014)
Oncol Rep
, vol.32
, pp. 1225-1233
-
-
Li, H.1
Meng, F.2
Ma, J.3
Yu, Y.4
Hua, X.5
Qin, J.6
Li, Y.7
-
47
-
-
84902543932
-
MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
-
Jia AY, Castillo-Martin M, Bonal DM, Sánchez-Carbayo M, Silva JM, Cordon-Cardo C. MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. Br J Cancer. 2014; 110:2945-2954.
-
(2014)
Br J Cancer
, vol.110
, pp. 2945-2954
-
-
Jia, A.Y.1
Castillo-Martin, M.2
Bonal, D.M.3
Sánchez-Carbayo, M.4
Silva, J.M.5
Cordon-Cardo, C.6
-
48
-
-
84861962359
-
Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients impairs their functional properties, via target gene Spred-1
-
Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol. 2012; 53:64-72.
-
(2012)
J Mol Cell Cardiol
, vol.53
, pp. 64-72
-
-
Meng, S.1
Cao, J.T.2
Zhang, B.3
Zhou, Q.4
Shen, C.X.5
Wang, C.Q.6
-
49
-
-
84882686726
-
Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer
-
Zhang Y, Wang X, Xu B, Wang B, Wang Z, Liang Y, Zhou J, Hu J, Jiang B. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep. 2013; 30:1976-1984.
-
(2013)
Oncol Rep
, vol.30
, pp. 1976-1984
-
-
Zhang, Y.1
Wang, X.2
Xu, B.3
Wang, B.4
Wang, Z.5
Liang, Y.6
Zhou, J.7
Hu, J.8
Jiang, B.9
-
50
-
-
84888005109
-
Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells
-
Guo CJ, Pan Q, Xiong H, Qiao YQ, Bian ZL, Zhong W, Sheng L, Li H, Shen L, Hua J, Ma X, Fang JY. Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells. FEBS Lett. 2013; 587:3792-3801.
-
(2013)
FEBS Lett
, vol.587
, pp. 3792-3801
-
-
Guo, C.J.1
Pan, Q.2
Xiong, H.3
Qiao, Y.Q.4
Bian, Z.L.5
Zhong, W.6
Sheng, L.7
Li, H.8
Shen, L.9
Hua, J.10
Ma, X.11
Fang, J.Y.12
-
51
-
-
84905046220
-
The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1a expression
-
Park MS, Kim BR, Dong SM, Lee SH, Kim DY, Rho SB. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1a expression. Oncotarget. 2014; 5:4935-4944.
-
(2014)
Oncotarget
, vol.5
, pp. 4935-4944
-
-
Park, M.S.1
Kim, B.R.2
Dong, S.M.3
Lee, S.H.4
Kim, D.Y.5
Rho, S.B.6
-
52
-
-
84899029955
-
Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
-
Siveen KS, Ahn KS, Ong TH, Shanmugam MK, Li F, Yap WN, Kumar AP, Fong CW, Tergaonkar V, Hui KM, Sethi G. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model. Oncotarget. 2014; 5:1897-1911.
-
(2014)
Oncotarget
, vol.5
, pp. 1897-1911
-
-
Siveen, K.S.1
Ahn, K.S.2
Ong, T.H.3
Shanmugam, M.K.4
Li, F.5
Yap, W.N.6
Kumar, A.P.7
Fong, C.W.8
Tergaonkar, V.9
Hui, K.M.10
Sethi, G.11
-
53
-
-
83555173668
-
Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways
-
Yao M, Zhang W, Zhang Q, Xing L, Xu A, Liu Q, Cui B. Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways. Lung. 2011; 189:453-460.
-
(2011)
Lung
, vol.189
, pp. 453-460
-
-
Yao, M.1
Zhang, W.2
Zhang, Q.3
Xing, L.4
Xu, A.5
Liu, Q.6
Cui, B.7
-
54
-
-
27944473690
-
VEGF as a key mediator of angiogenesis in cancer
-
Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005; 69(Suppl. 3):4-10.
-
(2005)
Oncology
, vol.69
, pp. 4-10
-
-
Carmeliet, P.1
-
55
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003; 9:669-676.
-
(2003)
Nat Med
, vol.9
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
56
-
-
47949089077
-
VEGF-targeted therapy: mechanisms of anti-tumour activity
-
Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 2008; 8:579-591.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 579-591
-
-
Ellis, L.M.1
Hicklin, D.J.2
-
57
-
-
70350228381
-
MicroRNAs: tools for cancer diagnostics
-
Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. Gut. 2009; 58:1546-1554.
-
(2009)
Gut
, vol.58
, pp. 1546-1554
-
-
Paranjape, T.1
Slack, F.J.2
Weidhaas, J.B.3
-
58
-
-
0026083903
-
Tumor angiogenesis and metastases-correlation in invasive breast carcinoma
-
Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastases-correlation in invasive breast carcinoma. N Engl J Med. 1991; 324:1-8.
-
(1991)
N Engl J Med
, vol.324
, pp. 1-8
-
-
Weidner, N.1
Semple, J.P.2
Welch, W.R.3
Folkman, J.4
|